ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,898,000 | +41.4% | 105,726 | -40.9% | 0.01% | +150.0% |
| Q1 2019 | $3,465,000 | +175.4% | 178,763 | +102.6% | 0.00% | 0.0% |
| Q4 2018 | $1,258,000 | -6.2% | 88,256 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,341,000 | -33.7% | 88,256 | -26.8% | 0.00% | -33.3% |
| Q2 2018 | $2,023,000 | -21.6% | 120,576 | -23.8% | 0.00% | 0.0% |
| Q1 2018 | $2,582,000 | +25.0% | 158,223 | -2.0% | 0.00% | 0.0% |
| Q4 2017 | $2,066,000 | +25.2% | 161,433 | +20.3% | 0.00% | +50.0% |
| Q3 2017 | $1,650,000 | +46.9% | 134,180 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,123,000 | +61.1% | 134,180 | +72.0% | 0.00% | +100.0% |
| Q1 2017 | $697,000 | +20.8% | 78,014 | +18.8% | 0.00% | 0.0% |
| Q4 2016 | $577,000 | -37.1% | 65,693 | -51.7% | 0.00% | -50.0% |
| Q3 2016 | $917,000 | +80.9% | 135,895 | +0.1% | 0.00% | +100.0% |
| Q2 2016 | $507,000 | +17.9% | 135,695 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $430,000 | -25.0% | 135,695 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $573,000 | -7.4% | 135,695 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $619,000 | – | 135,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |